Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 219
Filter
1.
J Med Internet Res ; 25: e42134, 2023 03 14.
Article in English | MEDLINE | ID: covidwho-2266078

ABSTRACT

BACKGROUND: Hypertension and diabetes are becoming increasingly prevalent worldwide. Telemedicine is an accessible and cost-effective means of supporting hypertension and diabetes management, especially as the COVID-19 pandemic has accelerated the adoption of technological solutions for care. However, to date, no review has examined the contextual factors that influence the implementation of telemedicine interventions for hypertension or diabetes worldwide. OBJECTIVE: We adopted a comprehensive implementation research perspective to synthesize the barriers to and facilitators of implementing telemedicine interventions for the management of hypertension, diabetes, or both. METHODS: We performed a scoping review involving searches in Ovid MEDLINE, Embase, CINAHL, Cochrane Library, Web of Science, and Google Scholar to identify studies published in English from 2017 to 2022 describing barriers and facilitators related to the implementation of telemedicine interventions for hypertension and diabetes management. The coding and synthesis of barriers and facilitators were guided by the Consolidated Framework for Implementation Research. RESULTS: Of the 17,687 records identified, 35 (0.2%) studies were included in our scoping review. We found that facilitators of and barriers to implementation were dispersed across the constructs of the Consolidated Framework for Implementation Research. Barriers related to cost, patient needs and resources (eg, lack of consideration of language needs, culture, and rural residency), and personal attributes of patients (eg, demographics and priorities) were the most common. Facilitators related to the design and packaging of the intervention (eg, user-friendliness), patient needs and resources (eg, personalized information that leveraged existing strengths), implementation climate (eg, intervention embedded into existing infrastructure), knowledge of and beliefs about the intervention (eg, convenience of telemedicine), and other personal attributes (eg, technical literacy) were the most common. CONCLUSIONS: Our findings suggest that the successful implementation of telemedicine interventions for hypertension and diabetes requires comprehensive efforts at the planning, execution, engagement, and reflection and evaluation stages of intervention implementation to address challenges at the individual, interpersonal, organizational, and environmental levels.


Subject(s)
Diabetes Mellitus , Health Services Accessibility , Hypertension , Implementation Science , Telemedicine , Humans , Diabetes Mellitus/therapy , Hypertension/therapy , Telemedicine/methods , Telemedicine/standards , Health Services Accessibility/standards , Patient Care Management/methods , Patient Care Management/standards
2.
Genève; Organisation mondiale de la Santé; 2023. (WHO/2019-nCoV/clinical/2023.1).
in French | WHOIRIS | ID: gwh-366649
3.
Ginebra; Organización Mundial de la Salud; 2023. (WHO/2019-nCoV/clinical/2023.1).
in Spanish | WHOIRIS | ID: gwh-366513
4.
Geneva; World Health Organization; 2023. (WHO/2019-nCoV/clinical/2023.1).
in English, Arabic, Chinese, Russian | WHOIRIS | ID: gwh-365580
5.
Ginebra; Organización Mundial de la Salud; 2022. (WHO/2019-nCoV/clinical/2022.2).
in Spanish | WHOIRIS | ID: gwh-365402
6.
Genève; Organisation mondiale de la Santé; 2022. (WHO/2019-nCoV/clinical/2022.2).
in French | WHOIRIS | ID: gwh-365401
7.
Ginebra; Organización Mundial de la Salud; 2022. (WHO/2019-nCoV/Clinical/2022.1).
in Spanish | WHOIRIS | ID: gwh-363046
8.
Genève; Organisation mondiale de la Santé; 2022. (WHO/2019-nCoV/Clinical/2022.1).
in French | WHOIRIS | ID: gwh-363044
11.
Geneva; World Health Organization; 2022. (WHO/2019-nCoV/Clinical/2022.2).
in English, Arabic, Chinese, Russian | WHOIRIS | ID: gwh-362783
13.
Geneva; World Health Organization; 2022. (WHO/2019-nCoV/Clinical/2022.1).
in English, Arabic, Russian, Chinese | WHOIRIS | ID: gwh-357004
20.
Geneva; World Health Organization; 2021. (WHO/2019-nCoV/clinical/2021.2).
in English, Arabic, Chinese | WHOIRIS | ID: gwh-349321
SELECTION OF CITATIONS
SEARCH DETAIL